Clinical Trials, Phase II as Topic
"Clinical Trials, Phase II as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.
Descriptor ID |
D017322
|
MeSH Number(s) |
E05.318.760.250.500.210 N05.715.360.775.088.500.210 N06.850.520.450.250.250.210
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Clinical Trials, Phase II as Topic".
Below are MeSH descriptors whose meaning is more specific than "Clinical Trials, Phase II as Topic".
This graph shows the total number of publications written about "Clinical Trials, Phase II as Topic" by people in this website by year, and whether "Clinical Trials, Phase II as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 4 | 3 | 7 |
1995 | 2 | 4 | 6 |
1996 | 1 | 5 | 6 |
1997 | 0 | 3 | 3 |
1998 | 2 | 0 | 2 |
1999 | 1 | 3 | 4 |
2000 | 1 | 3 | 4 |
2001 | 2 | 8 | 10 |
2002 | 2 | 5 | 7 |
2003 | 2 | 7 | 9 |
2004 | 2 | 7 | 9 |
2005 | 4 | 10 | 14 |
2006 | 5 | 12 | 17 |
2007 | 4 | 8 | 12 |
2008 | 7 | 8 | 15 |
2009 | 1 | 12 | 13 |
2010 | 3 | 15 | 18 |
2011 | 1 | 9 | 10 |
2012 | 2 | 15 | 17 |
2013 | 8 | 13 | 21 |
2014 | 3 | 12 | 15 |
2015 | 5 | 8 | 13 |
2016 | 1 | 16 | 17 |
2017 | 2 | 10 | 12 |
2018 | 3 | 16 | 19 |
2019 | 3 | 10 | 13 |
2020 | 2 | 19 | 21 |
2021 | 2 | 17 | 19 |
2022 | 2 | 10 | 12 |
2023 | 0 | 8 | 8 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Clinical Trials, Phase II as Topic" by people in Profiles.
-
A generalized phase 1-2-3 design integrating dose optimization with confirmatory treatment comparison. Biometrics. 2024 Jan 29; 80(1).
-
Plain language summary of erdafitinib in locally advanced or metastatic urothelial carcinoma: a phase 2 study with long-term follow-up. Future Oncol. 2024 Feb; 20(5):231-243.
-
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer. Future Oncol. 2023 Dec; 19(37):2445-2452.
-
Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours. Eur J Cancer. 2023 10; 192:113259.
-
BASIC: A Bayesian adaptive synthetic-control design for phase II clinical trials. Clin Trials. 2023 10; 20(5):486-496.
-
Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open-label, multicenter, single-arm, phase 2 trial. Cancer Med. 2023 06; 12(12):13352-13360.
-
Feasibility and preliminary efficacy of a virtual reality intervention targeting distress and anxiety in primary brain tumor patients at the time of clinical evaluation: Study protocol for a phase 2 clinical trial. BMC Cancer. 2023 Mar 21; 23(1):262.
-
Bayesian optimal phase II designs with dual-criterion decision making. Pharm Stat. 2023 Jul-Aug; 22(4):605-618.
-
Tisotumab vedotin in recurrent or metastatic cervical cancer. Curr Probl Cancer. 2023 06; 47(3):100952.
-
Bayesian treatment screening and selection using subgroup-specific utilities of response and toxicity. Biometrics. 2023 09; 79(3):2458-2473.